Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 1
1983 3
1984 1
1985 3
1987 5
1988 3
1989 1
1990 1
1991 2
1992 1
1993 2
1994 3
1995 1
1996 4
1997 3
1998 9
1999 105
2000 353
2001 457
2002 640
2003 773
2004 733
2005 819
2006 989
2007 1357
2008 1459
2009 1701
2010 1868
2011 1959
2012 2053
2013 2065
2014 2077
2015 2181
2016 1989
2017 1649
2018 1534
2019 1500
2020 1505
2021 1567
2022 1220
2023 879
2024 176

Text availability

Article attribute

Article type

Publication date

Search Results

29,478 results

Results by year

Filters applied: . Clear all
Page 1
Age-Related Macular Degeneration: A Review.
Fleckenstein M, Schmitz-Valckenberg S, Chakravarthy U. Fleckenstein M, et al. JAMA. 2024 Jan 9;331(2):147-157. doi: 10.1001/jama.2023.26074. JAMA. 2024. PMID: 38193957 Review.
Comparing cardiovascular adverse events in cancer patients: A meta-analysis of combination therapy with angiogenesis inhibitors and immune checkpoint inhibitors versus angiogenesis inhibitors alone.
Crocetto F, Ferro M, Buonerba C, Bardi L, Dolce P, Scafuri L, Mirto BF, Verde A, Sciarra A, Barone B, Calogero A, Sagnelli C, Busetto GM, Del Giudice F, Cilio S, Sonpavde G, Di Trolio R, Della Ratta GL, Barbato G, Di Lorenzo G. Crocetto F, et al. Crit Rev Oncol Hematol. 2023 Aug;188:104059. doi: 10.1016/j.critrevonc.2023.104059. Epub 2023 Jun 21. Crit Rev Oncol Hematol. 2023. PMID: 37353178 Review.
Age-related macular degeneration.
Bek T, Sørensen TL. Bek T, et al. Ugeskr Laeger. 2023 Nov 27;185(48):V05230316. Ugeskr Laeger. 2023. PMID: 38018728 Free article. Review. Danish.
Efficacy, durability, and safety of faricimab up to every 16 weeks in patients with neovascular age-related macular degeneration: 1-year results from the Japan subgroup of the phase 3 TENAYA trial.
Mori R, Honda S, Gomi F, Tsujikawa A, Koizumi H, Ochi H, Ohsawa S, Okada AA; TENAYA and LUCERNE Investigators. Mori R, et al. Jpn J Ophthalmol. 2023 May;67(3):301-310. doi: 10.1007/s10384-023-00985-w. Epub 2023 Apr 11. Jpn J Ophthalmol. 2023. PMID: 37039948 Free PMC article. Clinical Trial.
29,478 results
You have reached the last available page of results. Please see the User Guide for more information.